Floxabactin 150 mg tablets for dogs
Floxabactin 150 mg tablets for dogs
Authorised
- Enrofloxacin
Product identification
Medicine name:
Floxabactin 150 mg tablets for dogs
Floxabactin 150 mg Tabletten für Hunde
Active substance:
- Enrofloxacin
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Enrofloxacin150.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
Package description:
- Available only in German
- Box with 2 blisters (20 tablets); Alu- PVC.PVDC blister with 10 tablets
- Box with 2 blisters (20 tablets); Alu- PVC.PVDC blister with 10 tablets
- Box with 15 blisters (150 tablets); Alu- PVC.PVDC blister with 10 tablets
- Box with 15 blisters (150 tablets); Alu- PVC.PVDC blister with 10 tablets
- Box with 10 blisters (100 tablets); Alu- PVC.PVDC blister with 10 tablets
- Box with 1 blister (10 tablets); Alu-PVC.PVDC blister with 10 tablets
- Box with 1 blister (10 tablets); Alu-PVC.PVDC blister with 10 tablets
- Box with 1 blister (10 tablets); Alu-PVC.PVDC blister with 10 tablets
- Box with 1 blister (10 tablets); Alu-PVC.PVDC blister with 10 tablets
- Box with 3 blisters (30 tablets); Alu- PVC.PVDC blister with 10 tablets
- Box with 5 blisters (50 tablets); Alu- PVC.PVDC blister with 10 tablets
- Box with 5 blisters (50 tablets); Alu- PVC.PVDC blister with 10 tablets
- Box with 6 blisters (60 tablets); Alu- PVC.PVDC blister with 10 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Le Vet. B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- Austrian Agency For Health And Food Safety
Authorisation number:
- 8-00889
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0135/003
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Finland
-
France
-
Hungary
-
Ireland
-
Italy
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 24/01/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 17/06/2025
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 17/06/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 17/06/2025
Floxabactin PuAR NL-V-0135-001_003-DC final.pdf
English (PDF)
Download Published on: 24/01/2025